Effect of co-transporter blockers on non-synaptic epileptiform activity-computational simulation
Mariana Rodrigues Lopes1, Luiz Eduardo Canton Santos, Antônio Márcio Rodrigues
1Departamento de Engenharia de Biossistemas, Universidade Federal de São João del-Rei, São João del-Rei-MG, 39301-160-Brazil.
Physical Biology
|October 5, 2013
Summary
Cation-chloride co-transporters significantly influence epilepsy by affecting neuronal excitability. Blocking both NKCC (Na-K-2Cl) and KCC (K-Cl) transporters in neurons and glial cells can effectively suppress seizure activity.
Area of Science:
- Neuroscience
- Computational Biology
- Epilepsy Research
Background:
- Cation-chloride co-transporters play a critical role in regulating neuronal excitability and ionic homeostasis.
- Their dysregulation is implicated in the pathophysiology of epilepsy, influencing seizure susceptibility.
- Understanding the complex interplay of these transporters is crucial for developing targeted epilepsy therapies.
Purpose of the Study:
- To simulate non-synaptic epileptiform activity.
- To investigate the effects of blocking NKCC and KCC co-transporters on seizure activity.
- To elucidate the mechanisms underlying co-transporter function in epilepsy.
Main Methods:
- Electrochemical modeling of the granule cell layer in the rat hippocampus.
- Simulation of non-synaptic epileptiform activity.
- Analysis of the impact of blocking Na-K-2Cl (NKCC) and K-Cl (KCC) co-transporters.
Main Results:
- Potassium clearance relies on the interaction between the Na/K pump and NKCC co-transporters.
- Simultaneous blockade of neuronal NKCC and glial KCC efficiently suppressed epileptiform activity.
- The effect of co-transporter blockade on epileptiform activity can be either suppressive or enhancing, depending on the specific combination.
Conclusions:
- The Na/K pump and NKCC co-transporters are key players in potassium regulation.
- Targeting both NKCC in neurons and KCC in glial cells presents a promising strategy for suppressing epileptiform activity.
- Differential blockade of cation-chloride co-transporters offers potential for modulating seizure propensity.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...